Irreversible papain inhibitors

The diazomethyl ketone functional group was first observed to be an affinity label by Buchanan and co-workers who showed that the antibiotic azaserine, an O-diazoacetyl derivative, 9 inhibited an enzyme in the biosynthesis of purine by alkylation of a cysteine residue. 10 The acid protease pepsin was then observed to be inhibited by peptidyl diazomethyl ketones in the presence of copper ions with the resulting esterification of an aspartate residue. 11 Two peptidyl diazomethyl ketones, Z-Phe-CHN2 and Z-Phe-Phe-CHN2, were found to irreversibly inactivate papain, a cysteine protease. 12 Since these reports, many peptidyl diazomethyl ketones have been prepared primarily as inhibitors of various cysteine proteases. 7 Peptidyl diazomethyl ketones are also synthetic intermediates and have been used to prepare chloromethyl ketones (Section 15.1.3), 13 bromomethyl ketones (Section 15.1.3), acyloxymethyl ketones, 14 and (i-peptides. 15 A few peptidyl diazoalkyl ketones have been reported. 16,17 ... 

Fig. 11.10 (A) Burst kinetics for release of the leaving group from a substrate of a-chymotrypsin. (B) Titration of papain with the irreversible inhibitor 4-toluenesulphonamidomethyl chloromethyl ketone using methyl benzoylglycinate as substrate.

An experiment with an irreversible inhibitor should carry with it a control experiment involving the addition of a substrate if the location of the reaction with inhibitor is at the active site, then the addition of a substrate will slow down the rate of inhibition. For example, the reactivity of papain (5 pM) with a 1.71 pM solution of 4-toluenesulphonylamidomethyl chloromethyl ketone suffers a drop of 1.68-fold when the substrate (methyl hippurate) is changed from 12.7 to 21.1 mM. The inhibitor which reacts covalently with the enzyme should carry either a radioactive or spectroscopic tag which would enable the location of the altered amino acid to be determined in the sequence, and hence in the three-dimensional X-ray crystallographic map of the enzyme. An alternative approach is to design an inhibitor with groups (analogous to those attached to the substrate) which force it to bind at the active site (Scheme 11.18). 

The categorization of inhibitors of the papain super-family into five distinct groups has been reviewed in some detail and examples of each type have been cited [6]. These groups range in mechanism of action from those interacting in a purely non-covalent fashion to those that rely primarily on a group that is irreversibly reactive toward the active site thiol. A brief summary of these categories is presented here, with some illustrative examples the reader is directed to reference 6 for more detail. 

Inhibition. Since papain, ficin, and bromelain are all enzymes whose activity depends on a free SH group, it is to be expected that all thiol reagents act as inhibitors. Thus, a-halogen acids or amides and N-ethyl-maleimide irreversibly inhibit the thiol proteases. Heavy metal ions and organic mercurial salts inhibit in a fashion that can be reversed by low molecular weight thiols, particularly in the presence of EDTA which... 

Inhibitor peptides low molecular mass oligopeptide-fatty acid compounds of microbial origin which irreversibly inactivate plant and animal proteases. The inhibition is stoichiometric, i.e. 1 molecule I.p. inhibits 1 molecule enzyme. Examples are Leupeptin [acetyl-(or propionyl-)L-Leu-L-Leu-arginal the L-leu-cine can also be replaced by L-isovaline or L-valine], from Streptomyces species, inhibits cathepsin B, papain, trypsin, plasmin and cathepsin D, the effectiveness of the inhibition decreasing in that order. Pepsta-tin (isovaleryl-L-Val-L-Val-P-hydroxy-Y-NH2- -CH3-heptanoyl-L-Ala-P-hydroxy-Y-NHj-e-heptanoic acid), from actinomycetes, inhibits pepsin and cathepsin D. Chymostatin inhibits all known chymotrypsin types, cathepsin A, B, and D and papain. Antipain inhibits papain trypsin and plasmin. 

---